ScoreWhy is Alivus Life Sciences Ltd ?
1
High Management Efficiency with a high ROE of 18.73%
2
Company has a low Debt to Equity ratio (avg) at 0 times
3
Poor long term growth as Net Sales has grown by an annual rate of 4.88% and Operating profit at 4.00% over the last 5 years
4
Positive results in Dec 25
- NET SALES(Q) Highest at Rs 672.89 cr
- PBDIT(Q) Highest at Rs 231.28 cr.
- OPERATING PROFIT TO NET SALES(Q) Highest at 34.37%
5
With ROE of 18.7, it has a Fair valuation with a 3.8 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -19.76%, its profits have risen by 27.5% ; the PEG ratio of the company is 0.8
6
Majority shareholders : Promoters
7
Underperformed the market in the last 1 year
- Even though the market (BSE500) has generated returns of 9.12% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -19.76% returns
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Alivus Life should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Alivus Life for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Alivus Life
-19.46%
-0.53
37.01%
Sensex
8.49%
0.74
11.41%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
4.88%
EBIT Growth (5y)
4.00%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.20
Sales to Capital Employed (avg)
1.10
Tax Ratio
25.19%
Dividend Payout Ratio
58.54%
Pledged Shares
0
Institutional Holding
12.21%
ROCE (avg)
37.18%
ROE (avg)
18.73%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
21
Industry P/E
32
Price to Book Value
3.84
EV to EBIT
15.48
EV to EBITDA
14.07
EV to Capital Employed
4.54
EV to Sales
4.38
PEG Ratio
0.75
Dividend Yield
0.53%
ROCE (Latest)
27.80%
ROE (Latest)
18.68%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend12What is working for the Company
NET SALES(Q)
Highest at Rs 672.89 cr
PBDIT(Q)
Highest at Rs 231.28 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 34.37%
PBT LESS OI(Q)
Highest at Rs 210.12 cr.
PAT(Q)
Highest at Rs 169.69 cr.
EPS(Q)
Highest at Rs 12.25
-1What is not working for the Company
CASH AND CASH EQUIVALENTS(HY)
Lowest at Rs 19.18 cr
Loading Valuation Snapshot...
Here's what is working for Alivus Life
Net Sales - Quarterly
Highest at Rs 672.89 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 231.28 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 34.37%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 210.12 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 210.12 cr has Grown at 25.6% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 167.33 CrMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 169.69 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 169.69 cr has Grown at 28.0% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 132.60 CrMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 12.25
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Here's what is not working for Alivus Life
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 19.18 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
